Cargando…
You Have Got a Fast CAR: Chimeric Antigen Receptor NK Cells in Cancer Therapy
The clinical success stories of chimeric antigen receptor (CAR)-T cell therapy against B-cell malignancies have contributed to immunotherapy being at the forefront of cancer therapy today. Their success has fueled interest in improving CAR constructs, identifying additional antigens to target, and c...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140022/ https://www.ncbi.nlm.nih.gov/pubmed/32192067 http://dx.doi.org/10.3390/cancers12030706 |